How a CRO Qualifies an AI Vendor Under Its Own Quality System
The sponsor RFP now asks. Your QMS does not have an answer yet.
Somewhere in the last two funding cycles, a question migrated from the innovation slide into the qualification section of the sponsor RFP. It reads, with small variations, like this:
Describe any artificial intelligence or machine learning systems used in the delivery of these services. Describe how those systems are validated. Describe how their outputs are controlled under your quality management system. Identify who is accountable for the output.
That is not an innovation question. It is a vendor qualification question, and it lands on the quality unit, not the business development team. Most CROs currently answer it in one of two ways, and both of them lose the bid.
The two answers that lose
The first losing answer is denial. "We do not use AI systems in the delivery of these services." This was defensible eighteen months ago. It is now read by the sponsor as either untrue or uncompetitive, because the sponsor knows what their other bidders are proposing and knows what a modern medical writing or feasibility workflow looks like.
The second losing answer is a security certificate. The CRO forwards the vendor's SOC 2 report or ISO 27001 certificate. This is a category error, and a sponsor's quality lead spots it immediately. SOC 2 tells you the vendor will not lose your data. It tells you nothing about whether the vendor's output can be relied upon in a regulatory submission. Information security and computerized system validation are different disciplines answering different questions, and the RFP asked the second one.
Why the quality unit is genuinely stuck
This is worth stating plainly, because the difficulty is real and not a failure of anyone's diligence.
Computerized system validation, as practiced under GAMP 5 and as expected by inspectors, rests on an assumption that is decades old and entirely reasonable: the system is deterministic. You define the requirement, you specify the design, you test installation, operation, and performance, and you demonstrate that the same input produces the same output. Repeatability is the load-bearing beam. Every artifact in the validation package, every traceability matrix, every requalification trigger, sits on top of it.
A large language model does not offer repeatability in that sense. The same input can produce different output. Temperature settings and seeding reduce the variance but do not convert the system into a deterministic one, and a quality unit that writes a PQ protocol asserting otherwise has written a document it cannot defend under inspection.
So the CRO's quality function is being asked to validate something whose fundamental behaviour breaks the frame that validation was built on. That is not a paperwork problem. It is a structural one, and telling a Director of Quality to "just extend the existing SOP" is not an answer.
What the sponsor is actually asking for
Read the RFP question again and notice what it does not ask. It does not ask whether the model is accurate. It does not ask for a benchmark score. It asks how the output is controlled, and who is accountable.
That is an evidence question, not a model question.
The regulatory frame the sponsor has in mind is the one they already live in. Under 21 CFR Part 11 and EU Annex 11, records that support a regulated decision need attributable, contemporaneous, and enduring audit trails. Under ALCOA+, data supporting that decision needs to be attributable, legible, contemporaneous, original, and accurate. Under ICH E6(R3), the sponsor carries responsibility for the systems used in the conduct of the trial regardless of who operates them. None of those frameworks asks whether a model is clever. All of them ask whether you can show your work afterward, to someone hostile, years later.
This is the reframe that unsticks the whole problem:
You do not validate the model. You validate the evidence the model produces.
A probabilistic system that emits an unverifiable assertion is unvalidatable, and no amount of documentation fixes that. A probabilistic system whose output is checked by a separate, independent mechanism before a human sees it is a different object entirely. What enters your quality system is not the model's opinion. It is a checked artifact with a traceable provenance, and checked artifacts are things your QMS already knows how to handle.
Verification as a separate layer
This is the architecture principle behind NexTrial's Three-Gate Verification System, and it is worth describing structurally rather than as a product claim, because the structure is the part a CRO's quality unit needs to evaluate.
Gate 1, jurisdiction. The applicable regulatory requirement set is resolved before any generation happens. What FDA requires is not what ANVISA requires is not what CDSCO requires, and a system that treats jurisdiction as a post-hoc filter has already produced the wrong artifact. Gate 1 is designed to make jurisdiction an input constraint rather than a downstream check.
Gate 2, structural proof. The generated artifact is checked against the jurisdiction's requirement structure by a mechanism that is independent of the model that produced it. The point of independence is uncorrelated evidence: a model checking its own output shares the failure modes of the thing it is checking, which is why self-consistency scores and confidence numbers are not evidence. This structural proof layer has shipped and is in first validation with one sponsor. One sponsor is a small n, and it is stated here as a small n on purpose.
Gate 3, human oversight. The verdict goes to a qualified human who decides. Not a recommendation the human rubber-stamps, and not an automation the human supervises. The decision itself remains a human act, with the evidence attached to it.
A formal verification layer built in Lean 4 is in build. It is not live, and no performance figure is attached to it here, because a figure attached to an unshipped system is a fabricated figure.
The reason this structure matters for a CRO specifically: it produces an artifact you can put in front of a sponsor auditor without having to defend the model. The defensible object is the proof, not the prediction.
The jurisdiction layer, and why it differs by region
Three things are true at once for a CRO operating across borders, and they generate different versions of the same RFP question.
In Brazil, an international sponsor running under ANVISA faces a requirement structure that is genuinely distinct from FDA's, and the CRO carrying local delivery is the party that has to demonstrate conformance. Encoding that structure, rather than translating a US checklist, is the difference between a submission that survives and one that returns.
In India, CDSCO protocol compliance obligations for foreign sponsors sit alongside a delivery model that is frequently functional service provision rather than full service, which changes who holds the quality obligation and how the vendor qualification flows through to the sponsor.
In Europe, the open question is whether a given clinical trial support system falls inside the high-risk category under the EU AI Act, and what obligations attach if it does. That question is not settled for this class of tool, and any vendor telling a German CRO that it is settled is telling them something they will later have to retract. The correct posture is to build the technical documentation and logging that a high-risk classification would demand, and to be able to show it whether or not the classification lands.
Eight questions to put to any AI vendor
These are the questions a CRO quality unit can send to any vendor in the category, including us. They are ordered so that the first four disqualify quickly.
- When your system produces an output, what independent mechanism checks it before a human sees it? If the answer is a confidence score produced by the same model, there is no independent check.
- Is that checking mechanism correlated with the generating model? Shared training data, shared architecture, or shared prompt context means shared blind spots.
- What artifact does your system hand to our quality system, and what is its provenance record? You are qualifying the artifact, not the software.
- Show me the audit trail for a single decision, end to end. If it cannot be reconstructed on demand, it will not survive an inspection.
- Which jurisdiction's requirement structure was applied, and where is that encoding maintained? Jurisdiction handled as a translation layer is jurisdiction handled wrong.
- What in your platform is shipped, and what is in build? Ask for the answer in those words. The tense of the reply tells you what you are buying.
- Where does the human decision sit in your workflow, and can it be bypassed? If it can be bypassed under time pressure, it will be.
- What does your system store, and what does it never store? For a CRO holding sponsor data under contract, the boundary matters more than the capability.
A vendor that answers all eight in plain language is a vendor your quality unit can qualify. A vendor that answers them with benchmark scores is a vendor that has not understood the question.
The commercial point
The CRO that can hand a sponsor a validation package wins the bid. Not the CRO with the most AI, and not the CRO with the least. The bid is won by the one whose quality unit can answer the qualification section without flinching, because that answer is what converts an innovation claim into procurable service.
That is the actual demand. It is not a technology purchase. It is an evidence purchase.
Evidence, not substitution. The human decides.
FAQ
Can an AI system be validated under GAMP 5?
The validation frame assumes deterministic behaviour, and a large language model does not provide it. The workable approach is to validate the evidence the system produces rather than the model itself, by requiring an independent verification mechanism between the generated output and the human decision.
Does SOC 2 or ISO 27001 satisfy a sponsor's AI qualification question?
No. Those certifications address information security. The sponsor's qualification question addresses whether the output can be relied upon in a regulated decision, which is a computerized system validation question, not a security one.
Who is accountable for an AI output in a clinical trial under ICH E6(R3)?
Responsibility for systems used in the conduct of the trial remains with the sponsor regardless of who operates them, which is why the CRO's vendor qualification evidence flows through to the sponsor's own inspection readiness.
What is uncorrelated evidence?
Verification produced by a mechanism that does not share the generating model's architecture, training data, or context. Correlated checks reproduce the original error, which is why a model's own confidence score is not evidence of its correctness.
What should a CRO ask an AI vendor first?
What independent mechanism checks the output before a human sees it. If there is not one, the remaining questions do not matter.